David R. Booth

15.8k citations

115 papers · 6.1k indexed · 2 hit papers · h-index 41

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Nephrology top 1%

Papers in

Immunology 51
- T-cell and B-cell Immunology 21
- Immune Cell Function and Interaction 17
- Immunotherapy and Immune Responses 12
Pathology and Forensic Medicine 34
- Multiple Sclerosis Research Studies 27

Co-authors: Philip N. Hawkins Mark B. Pepys Graeme J. Stewart Grant P. Parnell Helen J. Lachmann Julian D. Gillmore A Bybee Vittorio Bellotti
Journals: PLoS ONE (8 papers)Genes and Immunity (6 papers)Frontiers in Immunology (5 papers)QJM (4 papers)Scientific Reports (3 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

David R. Booth

113 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis 1997 · 891 citations

Peers

Countries citing papers authored by David R. Booth

Since Specialization

Citations

This map shows the geographic impact of David R. Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Booth more than expected).

Fields of papers citing papers by David R. Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Booth. The network helps show where David R. Booth may publish in the future.

Co-authors

The 25 scholars most cited alongside David R. Booth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David R. Booth Line = papers co-authored together David R. Booth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immune Checkpoint Inhibitor-Induced Encephalitis: Hu Done It? American Journal of Respiratory and Critical Care Medicine ·David R. Booth, Thang Pham, Danny Verstraeten, Jamie Nicole LaBuzetta, Mazen Odish	2025	0
2	The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype EBioMedicine ·A. Requena López, Ali Afrasiabi, Stephen D. Schibeci, Sanjay Swaminathan, Grant P. Parnell, David R. Booth	2021	24
3	Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus Journal of Autoimmunity ·Ali Afrasiabi, A. Requena López, 肖艳云, Hamid Alinejad‐Rokny, Nicole Fewings, David R. Booth, Grant P. Parnell, Sanjay Swaminathan	2021	17
4	The Interaction of Human and Epstein–Barr Virus miRNAs with Multiple Sclerosis Risk Loci International Journal of Molecular Sciences ·Ali Afrasiabi, Nicole Fewings, Stephen D. Schibeci, A. Requena López, David R. Booth, Grant P. Parnell, Sanjay Swaminathan	2021	25
5	Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells Frontiers in Immunology ·A. Requena López, Ali Afrasiabi, Stephen D. Schibeci, Nicole Fewings, Grant P. Parnell, Sanjay Swaminathan, David R. Booth	2021	14
6	The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis Journal of Autoimmunity ·Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant P. Parnell, Stephen D. Schibeci, Jarem Edwards, Vargha, 喬大森, Marzena J. Fabis‐Pedrini, Allan G. Kermode, 守隆菅, Jacob L. McCauley, Dorothee Nickles, Sergio E. Baranzini, Therese Burke, Steve Vucic, Graeme J. Stewart, David R. Booth	2017	23
7	Altered regulatory T‐cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis Clinical & Translational Immunology ·Anderson P. Jones, Stephanie Trend, Scott N. Byrne, Marzena J. Fabis‐Pedrini, Sian Geldenhuys, David Nolan, David R. Booth, William M. Carroll, Robyn Lucas, Allan G. Kermode, Prue H. Hart	2017	23
8	The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function PLoS ONE ·Judith Field, Wenjia Zhang, Stephen D. Schibeci, Laura Johnson, Melissa Gresle, Louise Laverick, Grant P. Parnell, Graeme J. Stewart, Fiona C. McKay, Trevor J. Kilpatrick, Helmut Butzkueven, David R. Booth	2015	39
9	The clinical implications from the first hundred known MS susceptibility genes David R. Booth	2014	3
10	A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis PLoS ONE ·Carlos Riveros, JJ Rucklidge, Kaushal Gandhi, Fiona C. McKay, Mathew Cox, Regina Berretta, Ho‐Il Ji, Mario Inostroza-Ponta, Simon Broadley, Robert Heard, Steve Vucic, Graeme J. Stewart, David W. Williams, Rodney J. Scott, Jeannette Lechner‐Scott, David R. Booth, Pablo Moscato	2010	46
11	Interleukin 7 Receptor Alpha Chain Haplotypes Vary in Their Influence on Multiple Sclerosis Susceptibility and Response to Interferon Beta Journal of Interferon & Cytokine Research ·Julie Auer, Fiona C. McKay, Myra E. Martin-Adkins, F. TONNARD, Graeme J. Stewart, David R. Booth	2010	20
12	BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis Journal of Interferon & Cytokine Research ·Kaushal Gandhi, Fiona C. McKay, Stephen D. Schibeci, Jonathan W. Arthur, F. TONNARD, Graeme J. Stewart, David R. Booth	2008	26
13	Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission BMC Medical Genetics ·Ariel Arthur, Patricia J. Armati, Christopher R. Bye, Robert Heard, Graeme J. Stewart, John D. Pollard, David R. Booth	2008	58
14	An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians BMC Medical Genetics ·内田義孝, David R. Booth, Bruce Bennetts, Robert Heard, Justin P. Rubio, Graeme J. Stewart	2006	10
15	Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort Journal of Immunological Methods ·Fiona C. McKay, Stephen D. Schibeci, Robert Heard, Graeme J. Stewart, David R. Booth	2005	33
16	Transthyretin Ala97Ser is associated with familial amyloidotic polyneuropathy in a Chinese-Taiwanese family Human Mutation ·Helen J. Lachmann, David R. Booth, A Bybee, Philip N. Hawkins	2000	37
17	Hereditary renal amyloidosis associated with variant lysozyme in a large English family Nephrology Dialysis Transplantation ·Julian D. Gillmore, David R. Booth, S. Madhoo, Mark B. Pepys, Philip N. Hawkins	1999	57
18	Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I Kidney International ·M.R. Persey, David R. Booth, 최준삼, Maria Luiza Evangelista De Brito, Andrea Barthel, Jian Yan, Glenys A. Tennent, Philip N. Hawkins, Mark B. Pepys	1998	55
19	Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature ·David R. Booth, Margaret Sunde, Vittorio Bellotti, Carol V. Robinson, Winston L. Hutchinson, Paul E. Fraser, Philip N. Hawkins, Christopher M. Dobson, Sheena E. Radford, Colin Blake, Mark B. Pepys Hit paper breakdown →	1997	891
20	Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. Journal of Clinical Investigation ·David R. Booth, Shouyong Tan, S E Booth, GA Tennent, W. L. Hutchinson, J. Justin Hsuan, Nicholas F. Totty, O Truong, Anne K. Soutar, Philip N. Hawkins, Miquel Bruguera, Joan Caballería, 市松谷下, Josep M. Campistol, Mark B. Pepys	1996	75

About David R. Booth

David R. Booth is a scholar working on Immunology, Pathology and Forensic Medicine, Nephrology, Oncology and Molecular Biology, having authored 115 papers that have together received 6.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (27 papers), T-cell and B-cell Immunology (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (20 papers), Immune Cell Function and Interaction (17 papers), Immunotherapy and Immune Responses (12 papers), Systemic Lupus Erythematosus Research (7 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Parathyroid Disorders and Treatments (7 papers). The work is most often cited by research in Immunology (1.4k citations), Nephrology (469 citations), Molecular Biology (3.8k citations), Pathology and Forensic Medicine (915 citations) and Physiology (1.1k citations). David R. Booth has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Philip N. Hawkins, Mark B. Pepys, Graeme J. Stewart, Grant P. Parnell, Helen J. Lachmann, Julian D. Gillmore, A Bybee, Vittorio Bellotti, Carol V. Robinson and Colin Blake. Their work appears in journals such as PLoS ONE, Genes and Immunity, Frontiers in Immunology, QJM and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact